KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $3.4 billion.

  • Chemed's Treasury Shares rose 1810.56% to $3.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 billion, marking a year-over-year increase of 1810.56%. This contributed to the annual value of $3.1 billion for FY2024, which is 1496.81% up from last year.
  • Latest data reveals that Chemed reported Treasury Shares of $532500.0 as of Q3 2025, which was down 9762.99% from $125000.0 recorded in Q2 2025.
  • Chemed's 5-year Treasury Shares high stood at $22.9 million for Q4 2024, and its period low was $50000.0 during Q1 2025.
  • In the last 5 years, Chemed's Treasury Shares had a median value of $21.1 million in 2021 and averaged $12.8 million.
  • Its Treasury Shares has fluctuated over the past 5 years, first skyrocketed by 3333.27% in 2021, then surged by 304.64% in 2023.
  • Chemed's Treasury Shares (Quarter) stood at $2.4 billion in 2021, then grew by 6.5% to $2.6 billion in 2022, then rose by 5.08% to $2.7 billion in 2023, then grew by 14.97% to $3.1 billion in 2024, then rose by 9.75% to $3.4 billion in 2025.
  • Its last three reported values are $3.4 billion in Q3 2025, $3.2 billion for Q2 2025, and $3.2 billion during Q1 2025.